Know Cancer

or
forgot password

Non-interventional Study of Avastin in 1st Line Metastatic Colorectal Cancer


N/A
18 Years
N/A
Not Enrolling
Both
Colorectal Cancer

Thank you

Trial Information

Non-interventional Study of Avastin in 1st Line Metastatic Colorectal Cancer


Inclusion Criteria:



- Adult patients, >/= 18 years of age

- Histologically confirmed metastatic colorectal cancer without prior chemotherapy in
the metastatic setting

Exclusion Criteria:

- Contraindications for Avastin according to the locally approved package insert
(version 7 April 2006)

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Dosage/schedule of 1st-line Avastin

Outcome Time Frame:

approximately 3 years

Safety Issue:

No

Principal Investigator

Clinical Trials

Investigator Role:

Study Director

Investigator Affiliation:

Hoffmann-La Roche

Authority:

South Africa: Medicines Control Council of South Africa

Study ID:

ML22399

NCT ID:

NCT01674907

Start Date:

March 2010

Completion Date:

April 2012

Related Keywords:

  • Colorectal Cancer
  • Colorectal Neoplasms

Name

Location